Innovation
5 patent families (3 granted) — focus: Human necessities; filing pace slowing. Cited 2,436 times.
| Year | Filings |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Social engagement
Social engagement: 1K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Orbimed, Action Potential Venture Capital, Health Quest Capital, Samsara BioCapital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Other / undisclosed | 2 | 22% |
Hiring activity
No recent openings observed
No roles tracked in the last 12 months
8 Oct 2025 · Senior Field Clinical Engineers (#FCE)
8 Oct 2025 · Senior Field Clinical Engineer
Based on job postings tracked across public sources.
Recent activity
9 Apr 2026
Milestone
regulatory
25 Feb 2026
Event
Standard 2B randomized controlled trial evaluating sonodynamic therapy (SDT) in patients with newly diagnosed glioblastoma (GBM)